3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 6,115,388 shares, an increase of 135.0% from the June 15th total of 2,602,749 shares. Based on an average daily volume of 25 shares, the short-interest ratio is presently 244,615.5 days.
3SBio Stock Performance
Shares of 3SBio stock opened at $2.15 on Tuesday. The firm’s 50 day simple moving average is $2.39 and its two-hundred day simple moving average is $2.77. 3SBio has a 12-month low of $2.00 and a 12-month high of $4.74.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
Further Reading
- Five stocks we like better than 3SBio
- Wedbush Pounds the Table—Buy Sandisk Before August 5 Earnings
- Insiders Sell 2 AI Enablers: Investors Can Buy Into Their Futures
- Beyond the Foundry: 5 Infrastructure Stocks Tackling the AI Bottlenecks
- These 3 Stocks Are Beating the Market in 2026 and Just Announced Hefty Dividend Increases
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
